TY  - JOUR

T1  - The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer

JO  - Journal of Pharmaceutical Policy and Practice

UR  - https://doi.org/10.1186/s40545-023-00529-0

PY  - 2024/03/11

AU  - Sharman Moser S

AU  - Tanser F

AU  - Siegelmann-Danieli N

AU  - Apter L

AU  - Chodick G

AU  - Solomon J

ED  - 

DO  - DOI: 10.1186/s40545-023-00529-0

PB  - Informa UK Limited

VL  - 16

IS  - 1

SP  - 22

Y2  - 2025/02/05

ER  -